XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities:    
Net loss $ (9,241,000) $ (5,732,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 225,000 203,000
Change in fair value of contingent consideration (483,000) 0
Depreciation 36,000 56,000
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 518,000 366,000
Right of use asset 90,000 81,000
Accounts payable (295,000) (318,000)
Accrued expenses 265,000 (131,000)
Accrued employee benefits (272,000) (328,000)
Lease liability (101,000) (121,000)
Net Cash Used In Operating Activities (9,258,000) (5,924,000)
Cash Flows from Investing Activities    
Purchase of property and equipment (14,000) (14,000)
Cash paid for business combination, net of cash acquired (3,863,000) 0
Pre-acquisition loan to VCN (417,000) 0
Net Cash Used in Investing Activities (4,294,000) (14,000)
Cash Flows from Financing Activities    
Payment of VCN's CDTI loan (1,376,000)  
Proceeds from "at the market" stock issuance 0 65,960,000
Proceeds from issuance of common stock for warrant exercises 0 8,042,000
Net Cash Provided (used in) by Financing Activities (1,376,000) 74,002,000
Effects of FX on cash (35,000) 0
Net increase (decrease) in cash and cash equivalents and restricted cash (14,963,000) 68,064,000
Cash and cash equivalents and restricted at the beginning of this period 67,325,000 6,227,000
Cash and cash equivalents and restricted cash at the end of this period 52,362,000 74,291,000
Reconciliation of cash, cash equivalents, and restricted cash reported in the statement of financial position    
Cash and cash equivalents 52,266,000 74,291,000
Restricted cash included in other long-term assets 96,000 0
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows 52,362,000 74,291,000
Supplemental non-cash investing and financing activities:    
Fair value of contingent consideration issued in a business combination 12,158,000 0
Fair value of equity issued as consideration in a business combination 6,599,000 0
Effective settlement of pre-closing VCN financing 417,000 0
Goodwill measurement period adjustment 277,000 0
Effect of Series A Preferred Stock price adjustment 0 7,402,000
Right of use asset from operating lease 0 1,270,000
Conversion of Series B Preferred Stock 0 2,477,000
Deemed dividends for accretion of Series B Preferred Stock discount 0 1,497,000
In-kind dividends paid in preferred stock $ 0 $ 23,000